Atlas Trials

Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies

Clinical trial NCT00990717 · COMPLETED

Trial details

NCT number
NCT00990717
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaLymphomaMyelomaHodgkin's Disease
Start date
2005-03-01
Primary completion
2012-07-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.